Biohaven (BHVN) Other Working Capital Changes (2021 - 2026)
Biohaven (BHVN) posted Other Working Capital Changes of -$1.6 million for Q4 2022, down 769.96% sequentially from $233000.0 in Q4 2021, and down 769.96% YoY from $233000.0 in Q4 2021.
Biohaven (BHVN) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Biohaven has reported Other Working Capital Changes for 6 years, with the latest figure at -$12.6 million in Q1 2026.
- Quarterly Other Working Capital Changes fell 273.58% year-over-year to -$12.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.3 million (down 580.86% YoY) and the FY2025 annual result came in at -$3.5 million, up 56.1% from the prior year.
- Other Working Capital Changes declined to -$1.6 million in Q4 2022 per BHVN's latest filing, from $233000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $233000.0 in Q4 2021 and troughed at -$1.6 million in Q4 2022.
- A 5-year average of -$586941.2 and a median of $1.3 million in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 1604.69% in 2022, then sank 765.58% in 2024.
- Over 5 years, Other Working Capital Changes stood at $25.7 million in 2022, then sank by 95.12% to $1.3 million in 2023, then tumbled by 765.58% to -$8.3 million in 2024, then slipped by 5.78% to -$8.8 million in 2025, then slumped by 42.53% to -$12.6 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$12.6 million, -$8.8 million, and -$6.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.52 Mn |
| Jun 30, 2026 | -7.52 Mn |
| Jun 30, 2026 | -7.52 Mn |
| Mar 31, 2026 | -12.56 Mn |
| Mar 31, 2026 | -12.56 Mn |
| Mar 31, 2026 | -12.56 Mn |
| Dec 31, 2025 | -8.82 Mn |
| Dec 31, 2025 | -8.82 Mn |
| Dec 31, 2025 | -8.82 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Dec 31, 2024 | -8.33 Mn |
| Dec 31, 2024 | -8.33 Mn |